廣告
香港股市 將收市,收市時間:1 小時 2 分鐘
  • 恒指

    18,509.21
    +302.08 (+1.66%)
     
  • 國指

    6,560.28
    +123.19 (+1.91%)
     
  • 上證綜指

    3,104.82
    -8.22 (-0.26%)
     
  • 滬深300

    3,604.39
    -19.52 (-0.54%)
     
  • 美元

    7.8159
    +0.0026 (+0.03%)
     
  • 人民幣

    0.9259
    -0.0002 (-0.02%)
     
  • 道指

    38,225.66
    +322.37 (+0.85%)
     
  • 標普 500

    5,064.20
    +45.81 (+0.91%)
     
  • 納指

    15,840.96
    +235.48 (+1.51%)
     
  • 日圓

    0.0507
    +0.0002 (+0.32%)
     
  • 歐元

    8.3868
    +0.0089 (+0.11%)
     
  • 英鎊

    9.8030
    +0.0110 (+0.11%)
     
  • 紐約期油

    79.23
    +0.28 (+0.35%)
     
  • 金價

    2,307.30
    -2.30 (-0.10%)
     
  • Bitcoin

    59,351.18
    +1,641.58 (+2.84%)
     
  • CMC Crypto 200

    1,293.60
    +16.62 (+1.30%)
     

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

Voyager Therapeutics has surely tried investors’ patience since it came public eight years ago. The biotech firm’s stock has fallen as low as $2.50 from a peak of $30, as its early programs to treat neurological diseases didn’t pan out. Analysts at Guggenheim Securities initiated coverage of the Lexington, Mass.-based biotech with a Buy rating earlier this week.